Hol
Well-known
Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. accused the Biden administration of manipulating abortion pill safety data.
Kennedy Jr. made the remark during a Senate Finance Committee hearing on Thursday about the Trump administration’s health care agenda. Sen. James Lankford (R-OK) specifically questioned the HHS secretary about the Food and Drug Administration’s (FDA) safety review of mifepristone, the first drug used in a two-drug medication abortion regimen, after a study was released in April suggesting the abortion pill complications are 22 times higher than previously reported. Lankford said: "You’ve made public statements on this, and the FDA commissioner has made public statements on the issue of reviewing the safety issues of mifepristone. Your comments early on were that every drug needs to be treated the same, needs to look at the same and not have political biases in how things are actually examined. There were a lot of changes on the allocation of mifepristone for elective abortions under the Biden administration. It’s now open anyone without a prescription on it. You don’t have to go through a doctor on it. There’s all kinds of issues that are happening now on it."
...
Kennedy Jr. said in May that he ordered the FDA to conduct a “complete review” of the abortion pill, in response to the new study from the Ethics and Public Policy Center (EPPC).
That study found that 10.93 percent of women who had mifepristone abortions experienced severe complications including sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following the abortion. The percentage is significantly higher than the less than 0.5 percent in clinical trials reported on the FDA-approved drug label. The study is based on analysis of data from an all-payer insurance claims database that includes 865,727 prescribed mifepristone abortions from 2017 to 2023.
www.breitbart.com
Kennedy Jr. made the remark during a Senate Finance Committee hearing on Thursday about the Trump administration’s health care agenda. Sen. James Lankford (R-OK) specifically questioned the HHS secretary about the Food and Drug Administration’s (FDA) safety review of mifepristone, the first drug used in a two-drug medication abortion regimen, after a study was released in April suggesting the abortion pill complications are 22 times higher than previously reported. Lankford said: "You’ve made public statements on this, and the FDA commissioner has made public statements on the issue of reviewing the safety issues of mifepristone. Your comments early on were that every drug needs to be treated the same, needs to look at the same and not have political biases in how things are actually examined. There were a lot of changes on the allocation of mifepristone for elective abortions under the Biden administration. It’s now open anyone without a prescription on it. You don’t have to go through a doctor on it. There’s all kinds of issues that are happening now on it."
...
Kennedy Jr. said in May that he ordered the FDA to conduct a “complete review” of the abortion pill, in response to the new study from the Ethics and Public Policy Center (EPPC).
That study found that 10.93 percent of women who had mifepristone abortions experienced severe complications including sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following the abortion. The percentage is significantly higher than the less than 0.5 percent in clinical trials reported on the FDA-approved drug label. The study is based on analysis of data from an all-payer insurance claims database that includes 865,727 prescribed mifepristone abortions from 2017 to 2023.
RFK Jr. Says Biden Admin ‘Twisted’ Abortion Pill Safety Data
HHS Secretary Robert F. Kennedy Jr. accused the Biden administration of manipulating abortion pill safety data.
www.breitbart.com
